Cue Biopharma, Inc. | Collaboration Agreements | Business Contracts

First Amendment to Collaboration, License and Option Agreement, dated March 15, 2019, between the Registrant and LG CHEM LTD (Filed With SEC on March 9, 2021)

Second Amendment to Collaboration, License and Option Agreement, dated August 5, 2019, between the Registrant and LG CHEM LTD (Filed With SEC on March 9, 2021)

Third Amendment to Collaboration, License and Option Agreement, dated October 29, 2019, between the Registrant and LG CHEM LTD (Filed With SEC on March 9, 2021)

Fourth Amendment to Collaboration, License and Option Agreement, dated December 18, 2019, between the Registrant and LG CHEM LTD (Filed With SEC on March 9, 2021)

Fifth Amendment to Collaboration, License and Option Agreement, dated January 10, 2020, between the Registrant and LG CHEM LTD (Filed With SEC on March 9, 2021)

Sixth Amendment to Collaboration, License and Option Agreement, dated February 14, 2020, between the Registrant and LG CHEM LTD (Filed With SEC on March 9, 2021)

Seventh Amendment to Collaboration, License and Option Agreement, dated May 14, 2020, between the Registrant and LG CHEM LTD (Filed With SEC on March 9, 2021)

Eighth Amendment to Collaboration, License and Option Agreement, dated December 7, 2020, between the Registrant and LG CHEM LTD (Filed With SEC on March 9, 2021)

First Amendment to the Exclusive Patent License and Research Collaboration Agreement with Merck Sharp & Dohme Corp. dated November 9, 2020 (Filed With SEC on March 9, 2021)

Cue Biopharma, Inc. (38) | Collaboration Agreements (9)